Directly observed therapy of sofosbuvir/ribavirin +/− peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT)-Reference-Cited by-同舟云学术

Directly observed therapy of sofosbuvir/ribavirin +/− peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT)

Published:2017-08-14 Issue:1 Volume:25 Page:37-46
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Solomon S. S.¹²³^ORCID,Sulkowski M. S.¹,Amrose P.³,Srikrishnan A. K.³,McFall A. M.²,Ramasamy B.³,Kumar M. S.³,Anand S.³,Thomas D. L.¹²,Mehta S. H.²

Affiliation:

1. Department of Medicine; Johns Hopkins School of Medicine; Baltimore MD USA

2. Department of Epidemiology; Johns Hopkins Bloomberg School of Public Health; Baltimore MD USA

3. YR Gaitonde Centre for AIDS Research and Education; Chennai India

Funder

National Institutes of Health

Johns Hopkins University

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12761/fullpdf

Reference43 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Blach;Lancet Gastroenterol Hepatol,2017

2. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

3. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis;Kowdley;N Engl J Med,2014

4. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

5. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection;Sulkowski;N Engl J Med,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GRAND PLAN: Safety and Efficacy of Glecaprevir/Pibrentasvir for the Treatment of Hepatitis C Virus Infection Among People Initially Disengaged From Health Care Who Use Drugs—A Systematic Multidisciplinary Approach;Open Forum Infectious Diseases;2024-02-29

2. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset;Journal of Hepatology;2019-07

3. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India;International Journal of Drug Policy;2018-07

4. STUDY TO KNOW THE ADVERSE EFFECTS OF RIBAVIRIN AND SOFOSBUVIR USED FOR TREATMENT OF CHRONIC HEPATITIS C PATIENTS AND ITS CORRELATION TO RAPID VIROLOGICAL RESPONSE;INDO AM J PHARM SCI;2018

5. Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis;Journal of Virus Eradication;2018-04